The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 4 , Pages 848-859 , April 2010

Are stentless valves hemodynamically superior to stented valves? Long-term follow-up of a randomized trial comparing Carpentier–Edwards pericardial valve with the Toronto Stentless Porcine Valve

Read at the Eighty-eighth Annual Meeting of The American Association for Thoracic Surgery, San Diego, Calif, May 10–14, 2008.

Received 7 May 2008 ,Revised 8 March 2009 ,Accepted 27 April 2009.

References 

  1. Lund O, Bland M. Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement. J Thorac Cardiovasc Surg. 2006;132:20–26
  2. Roberts WC, Ko JM, Filardo G, et al. Valve structure and survival in quadragenarians having aortic valve replacement for aortic stenosis (+/-aortic regurgitation) with versus without coronary artery bypass grafting at a single US medical center (1993 to 2005). Am J Cardiol. 2007;100:1683–1690
  3. Le Tourneau T, Marechaux S, Vincentelli A, et al. Cardiovascular risk factors as predictors of early and late survival after bioprosthetic valve replacement for aortic stenosis. J Heart Valve Dis. 2007;16:483–488
  4. Ruel M, Chan V, Bédard P, et al. Very long-term survival implications of heart valve replacement with tissue versus mechanical prostheses in adults <60 years of age. Circulation. 2007;116(suppl):I294–I300
  5. Auriemma S, D'Onofrio A, Brunelli M, et al. Long-term results of aortic valve replacement with Edwards Prima Plus stentless bioprosthesis: eleven years' follow-up. J Heart Valve Dis. 2006;15:691–695
  6. Naslafkih A, François S, Fix JM, Khoury A. Aortic valve replacement and long-term prognosis. J Insur Med. 2006;38:126–135
  7. Rizzoli G, Mirone S, Ius P, et al. Fifteen-year results with the Hancock II valve: a multicenter experience. J Thorac Cardiovasc Surg. 2006;132:602–609
  8. Kvidal P, Bergström R, Hörte LG, Ståhle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol. 2000;35:747–756
  9. David TE, Pollick C, Bos J. Aortic valve replacement with the stentless porcine aortic bioprosthesis. J Thorac Cardiovasc Surg. 1990;99:113–118
  10. Jin XY, Gibson DG, Yacoub MH, Pepper JR. Perioperative assessment of aortic homograft, Toronto Stentless Valve, and stented valve in the aortic position. Ann Thorac Surg. 1995;60(suppl):S395–S401
  11. Sidiropoulos A, Hotz H, Tschesnow J, Konertz W. Stentless porcine bioprosthesis for all types of aortic root pathology. Eur J Cardiothorac Surg. 1997;11:917–921
  12. Westaby S. Aortic valve replacement with the Freestyle stentless xenograft. Ann Thorac Surg. 1995;60(suppl):S422–S427
  13. Pillai R, Spriggings D, Amarasena N, et al. Stentless aortic bioprosthesis? The way forward: early experience with the Edwards valve. Ann Thorac Surg. 1993;56:88–91
  14. Chambers JB, Rimington HM, Hodson F, Rajani R, Blauth CI. The subcoronary Toronto stentless versus supra-annular Perimount stented replacement aortic valve: early clinical and hemodynamic results of a randomized comparison in 160 patients. J Thorac Cardiovasc Surg. 2006;131:878–2
  15. Nessmith MG, Fukuta H, Brucks S, Little WC. Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery. Am J Cardiol. 2005;96:1445–1448
  16. Kunadian B, Vijayalakshmi K, Thornley , et al. Meta-analysis of valve hemodynamics and left ventricular mass regression for stentless verus stented aortic valves. Ann Thorac Surg. 2007;84:73–78
  17. Kallikourdis A, Jacob S. Is a stentless aortic valve superior to conventional bioprosthetic valves for aortic valve replacement?. Interact Cardiovasc Thorac Surg. 2007;6:665–672
  18. Cohen G, Christakis GT, Joyner CD, et al. Are stentless valves hemodynamically superior to stented valves? A prospective randomized trial. Ann Thorac Surg. 2002;73:767–775
  19. Akins CW, Miller DC, Turina MI, et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg. 2008;135:732–738
  20. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller CD, Weisel RD. Ad Hoc Liason Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of the American Association for Thoracic Surgery and the Society of Thoracic Surgeons. J Thorac Cardiovasc Surg. 1996;112:708–711
  21. Task Force of the Echocardiography Section of the Canadian Cardiovascular Society and the Canadian Hypertension Society. Guidelines from the Canadian Cardiovascular Society and the Canadian Hypertension Society on the echocardiographic determination of left ventricular mass. Can J Cardiol. 1995;11:391–395
  22. Lee VS, Resnick D, Bundy JM, Simonetti OP, Lee P, Weinreb JC. Cardiac function: MR evaluation in one breath hold with real-time true fast imaging with steady-state precession. Radiology. 2002;222:835–842
  23. Bolster BD, McVeigh ER, Zerhouni EA. Myocardial tagging in polar coordinates with use of striped tags. Radiology. 1990;177:769–772
  24. Zhu Y, Drangova M, Pelc NJ. Estimation of deformatoin gradient and strain from cine-PC velocity data. IEEE Trans Med Imaging. 1997;16:840–851
  25. Hlatky MA, Boineau RE, Higginbothan MB, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989;64:651–664
  26. Almeida SS, Azevedo A, Castro A, et al. B-type natriuretic peptide is related to left ventricular mass in hypertensive patients but not in athletes. Cardiology. 2002;98:113–115
  27. Zoccali C, Mallamaci F, Benedetto FA, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol. 2001;12:1508–1515
  28. Luchner A, Burnett JC, Jougasaki M, et al. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens. 2000;18:1121–1128
  29. McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left ventricular systolic dysfunction. Lancet. 1998;351:9–13
  30. Bergler-Klein J, Mundigler G, Pibarot P, et al. B-type natriuretic peptide in low-flow, low gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study. Circulation. 2007;115:2848–2855
  31. Ali A, Halstead JC, Cafferty F, et al. Early clinical and hemodynamic outcomes after stented and stentless aortic valve replacement: results from a randomized controlled trial. Ann Thorac Surg. 2007;83:2162–2168
  32. Perez de Arenaza D, Lees B, Flather M, et al. Randomized comparison of stentless versus stented valves for aortic stenosis: effects on left ventricular mass. Circulation. 2005;112:2696–2702
  33. Dunning J, Graham RJ, Thambyrajah J, Stewart MJ, Kendall SW, Hunter S. Stentless vs. stented aortic valve bioprostheses: a prospective randomized controlled trial. Eur Heart J. 2007;28:2369–2374
  34. Raja SG, Macarthur KJ, Pollock JC. Impact of stentless aortic valves on left ventricular function and hypertrophy: current best available evidence. J Card Surg. 2006;21:313–319
  35. Lehmann S, Walther T, Kempfert J, Leontjev S, Rastan A, Falk V, et al. Stentless versus conventional xenograft aortic valve replacement: midterm results of a prospectively randomized trial. Ann Thorac Surg. 2007;84:467–472
  36. Tatineni S, Barner HB, Pearson AC, Halbe D, Woodruff R, Labovitz AJ. Rest and exercise evaluation of St. Jude Medical and Medtronic-Hall prostheses. Influence of primary lesion, valvular type, valvular size and left ventricular function. Circulation. 1999;80:16–23
  37. Silberman S, Shaheen J, Fink D, et al. Comparison of exercise hemodynamics among non-stented aortic bioprostheses, mechanical valves, and normal native aortic valves. J Card Surg. 1998;13:412–416
  38. Zabalgoitia M, Kopek K, Oneschuk L, et al. Use of dobutamine stress echocardiography in assessing mechanical aortic prostheses: comparison with exercise echocardiography. J Heart Valve Dis. 1997;6:253–257
  39. Sullivan JM, Vander Zwaag R, El Zeky F, Ramanathan KB, Mirvis DM. Left ventricular hypertrophy: effect on survival. J Am Coll Cardiol. 1993;22:508–513
  40. Levy D, Anderson KM, Savage DD, Balkus SA, Kannel WB, Castelli WB. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol. 1987;60:560–565
  41. Levy D. Clinical significance of left ventricular hypertrophy: insights from the Framingham study. J Cardiovasc Pharmacol. 1991;17(suppl):S1–S6
  42. Gelsomino S, Frassani R, Morocutti G, et al. Time course of left ventricular remodeling after stentless aortic valve replacement. Am Heart J. 2001;142:556–562
  43. Gerber IL, Stewart RA, Legget ME, et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation. 2003;107:1884–1890
  44. Talwar S, Downie PF, Squire IB, Davies JE, Barnett DB, Ng LL. Plasma N-terminal pro-BNP and cardiotrophin-1 are elevated in aortic stenosis. Eur J Heart Fail. 2001;3:15–19
  45. Bergler-Klein J, Mundigler G, Pibarot P, et al. B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study. Circulation. 2007;115:2848–2855
  46. Bakhtiary F, Schiemann M, Dzemali O, et al. Stentless bioprostheses improve postoperative coronary flow more than stented prostheses after valve replacement for aortic stenosis. Impact on coronary flow. J Thorac Cardiovasc Surg. 2006;131:883–888
  47. Scherer M, Abdel-Rahman U, Dzermali O, et al. Pathophysiology of coronary artery flow during extracorporeal circulation (ECC), myocardial ischemia and mechanical aortic valve replacement—an experimental study. Cardiology. 2003;1:30–35
  48. Bakhtiary F, Schiemann M, Dzemali O, et al. Impact of patient-prosthesis mismatch and aortic valve design on coronary flow reserve after aortic valve replacement. J Am Coll Cardiol. 2007;49:790–796
  49. Timek TA, Green GR, Tibayan FA, et al. Aorto-mitral annular dynamics. Ann Thorac Surg. 2003;76:1944–1950
  50. Nygaard H, Paulsen PK, Hasenkam JM, Kromann-Hansen O, Pedersen EM, Rovsing PE. Quantitation of the turbulent stress distribution downstream of normal, diseased and artificial aortic valves in humans. J Cardiothorac Surg. 1992;6:609–617
  51. Kazui T, Izumoto H, Yoshioka K, Kawazoe K. Dynamic morphologic changes in the normal aortic annulus during systole and diastole. J Heart Valve Dis. 2006;15:617–621
  52. Desai ND, Merin O, Cohen GN, et al. Long-term results of aortic valve replacement with the St. Jude Toronto stentless porcine valve. Ann Thorac Surg. 2004;78:2076–2083
  53. Bach DS, Goldman B, Verrier E, et al. Durability and prevalence of aortic regurgitation nine years after aortic valve replacement with the Toronto SPV stentless bioprosthesis. J Heart Valve Dis. 2004;13:64–72
  54. Bach DS, Cartier PC, Kon ND, Johnson KG, Deeb GM, Doty DB. Impact of implant technique following freestyle stentless aortic valve replacement. Freestyle Valve Study Group. Ann Thorac Surg. 2002;74:1107–1113
  55. Ennker JA, Albert AA, Rosendahl UP, Ennker IC, Dalladaku F, Florath I. Ten-year experience with stentless aortic valves: full-root versus subcoronary implantation. Ann Thorac Surg. 2008;85:445–453
  56. Borger MA, Prasongsukarn K, Armstrong S, Feindel CM, David TE. Stentless aortic valve reoperations: a surgical challenge. Ann Thorac Surg. 2007;84:737–743

 Disclosures: None.

 Supported by the Heart and Stroke Foundation of Canada.

PII: S0022-5223(09)01401-9

doi: 10.1016/j.jtcvs.2009.04.067

The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 4 , Pages 848-859 , April 2010

Article Tools

* Image Usage & Resolution